Press coverage about National Health Investors (NYSE:NHI) has been trending somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 45.4196419612317 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:
- Stock for Low Risk Taking Investors: National Health Investors, Inc. (NHI) (wallstreetinvestorplace.com)
- National Health Investors, Inc. (NHI) – 52-Weeks Low Effect in Stock (thestocksnews.com)
- Zacks: Analysts Anticipate National Health Investors Inc (NHI) Will Post Quarterly Sales of $72.38 Million (americanbankingnews.com)
- On Friday National Health Investors, Inc. (NHI) stock price settles at $66.31 with movement of 0.47% (nasdaqexpress.com)
- National Health Investors, Inc. (NHI) Ex-Dividend Date Scheduled for March 28, 2018 (nasdaq.com)
NHI has been the topic of several research analyst reports. Stephens set a $79.00 price objective on shares of National Health Investors and gave the stock a “buy” rating in a research note on Friday, January 12th. Stifel Nicolaus set a $76.00 price objective on shares of National Health Investors and gave the stock a “buy” rating in a research note on Saturday, February 17th. Hilliard Lyons raised shares of National Health Investors from a “neutral” rating to a “buy” rating in a research note on Friday, February 16th. BMO Capital Markets set a $70.00 price objective on shares of National Health Investors and gave the stock a “hold” rating in a research note on Monday, March 26th. Finally, Mizuho reaffirmed a “hold” rating and set a $70.00 price objective on shares of National Health Investors in a research note on Monday, February 26th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $76.50.
National Health Investors (NYSE:NHI) last announced its earnings results on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.33 by ($0.43). National Health Investors had a return on equity of 12.20% and a net margin of 57.19%. The company had revenue of $71.06 million for the quarter, compared to analyst estimates of $71.36 million. research analysts predict that National Health Investors will post 5.5 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, May 10th. Stockholders of record on Friday, March 30th will be given a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.94%. This is a positive change from National Health Investors’s previous quarterly dividend of $0.95. The ex-dividend date is Wednesday, March 28th. National Health Investors’s dividend payout ratio is presently 75.05%.
In related news, VP John L. Spaid bought 500 shares of National Health Investors stock in a transaction dated Thursday, February 22nd. The shares were bought at an average cost of $64.95 per share, for a total transaction of $32,475.00. Following the completion of the transaction, the vice president now owns 971 shares of the company’s stock, valued at $63,066.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn bought 2,000 shares of National Health Investors stock in a transaction dated Thursday, February 22nd. The shares were bought at an average price of $65.47 per share, for a total transaction of $130,940.00. Following the completion of the transaction, the chief executive officer now directly owns 10,580 shares of the company’s stock, valued at approximately $692,672.60. The disclosure for this purchase can be found here. Insiders have bought 2,812 shares of company stock worth $183,910 over the last quarter. 5.19% of the stock is owned by company insiders.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.